Perspectives in drug discovery and design

Perspectives in drug discovery and designschema:ProductModel

3D QSAR in drug design: ligand-protein interactions and molecular similarity / ed. by Hugo Kubinyi, Gerd Folkers, Yvonne C. Martinschema:ProductModel 3D QSAR in drug design: recent advances / ed. by Hugo Kubinyi, Gerd Folkers, Yvonne C. Martinschema:ProductModel Animal toxins and potassium channels / ed. by H. Darbon, J.-M. Sabatierschema:ProductModel Antisense therapeutics : progress and prospects / ed. by G.L. Trainorschema:ProductModel Combinatorial libraries : the theory and practice of combinatorial chemistry / guest ed. Richard A. Houghtonschema:ProductModel Computational methods for the analysis of molecular diversity / ed. by P. Willettschema:ProductModel Cysteine proteases : evolution, function, and inhibitor design / ed. by J.H. McKerrow, M.N.G. Jamesschema:ProductModel De Novo design / ed. by K. Müllerschema:ProductModel HIV infection in CD4-cells / ed. by J. Fantini, J.-M. Sabatierschema:ProductModel Hydrophobicity and solvation in drug designschema:ProductModel Immunosuppression / guest ed.: Matthew J. Wyvratt and Nolan H. Sigalschema:ProductModel Proteases as therapeutic targets / guest ed.: Charles S. Craik and Christine Debouckschema:ProductModel Therapeutic approaches to HIV / ed. P.S. Anderson ... [et al.]schema:ProductModel Virtual screening: an alternative or complement to high throughput screening? / ed. by Gerhard Klebeschema:ProductModel